Fig. 1From: Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysisStudy selection process. * “Other” reasons included commentary and opinion articles, protocols, review studies, lab science studies, and studies with no outcomes of interestBack to article page